News | October 03, 2023
Briefs: Aurobindo Pharma and Balaxi Pharmaceuticals
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
Diofan Ultra736 provides ultra-high water vapor barrier with excellent thermoformability, unlocking the potential to design thinner and more sustainable blister films
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
The delegation's visit covered a wide range of topics
WINLEVI works differently from any other topical acne treatment
Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
Commenced operations in flood-affected Himachal Pradesh
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Subscribe To Our Newsletter & Stay Updated
